Somatostatin Containing δ-Cell Number Is Reduced in Type-2 Diabetes
Recent developments suggest that increased glucagon and decreased somatostatin secretion from the pancreas contribute to hyperglycaemia in type-2 diabetes (T2D) patients. There is a huge need to understand changes in glucagon and somatostatin secretion to develop potential anti-diabetic drugs. To fu...
Main Authors: | Lakshmi Kothegala, Caroline Miranda, Meetu Singh, Jean-Philippe Krieger, Nikhil R. Gandasi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/4/3449 |
Similar Items
-
The Eye as a Transplantation Site to Monitor Pancreatic Islet Cell Plasticity
by: Erwin Ilegems, et al.
Published: (2021-04-01) -
Human islet isolation: status and future considerations*
by: R. Bottino, et al.
Published: (2019-04-01) -
Development of the insulin secretion mechanism in fetal and neonatal rat pancreatic B-cells: response to glucose, K+, theophylline, and carbamylcholine
by: A.C. Mendonça, et al.
Published: (1998-06-01) -
Cilia Action in Islets: Lessons From Mouse Models
by: Jung Hoon Cho, et al.
Published: (2022-06-01) -
The changing view of insulin granule mobility: From conveyor belt to signaling hub
by: Bastian Gaus, et al.
Published: (2022-09-01)